Evommune Inc. (EVMN) vs Century Therapeutics, Inc. (IPSC)

Evommune Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Evommune Inc. and Century Therapeutics, Inc. are of similar size ($309.9M and $306.0M). Across the 10 metrics below, Century Therapeutics, Inc. leads on 6 and Evommune Inc. on 4.

Valuation

Metric EVMN IPSC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 2.99 11.47
P/B 1.10 1.48 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.95 10.73
Earnings yield (130.22%) (55.69%) (28.84%)
Free cash flow yield (24.39%) (25.62%) (23.03%)

Profitability

Metric EVMN IPSC Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (141.99%) (49.65%) (57.72%)
Return on assets (62.71%) (38.41%) (49.22%)
Return on invested capital (82.46%) (64.92%) 0.00%

Growth

Metric EVMN IPSC Biotechnology median
Revenue growth (TTM) — 8,286.72% 5.64%
EPS growth (last fiscal year) 75.23% 93.12% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EVMN IPSC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.68 8.28 4.73
Net debt to EBITDA 1.87 17.95 0.96

Dividend

Metric EVMN IPSC Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric EVMN IPSC Biotechnology median
Market cap 309.93m 306.02m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack